All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 19, 2022
Home » Topics » Science

Science
Science RSS Feed RSS

Neural chip

Bench Press for Dec. 6, 2019

Dec. 6, 2019
No Comments
BioWorld looks at translational medicine.
Read More

New PCa treatment strategy may overcome resistance

Dec. 6, 2019
By John Fox
No Comments
Targeting prostate cancer (PCa) neuroendocrine (NE) cells via inhibition of the C-X-C motif chemokine receptor 2 (CXCR2) is an androgen receptor (AR)-independent therapeutic strategy that can improve the efficacy of treatment for PCa, a leading cause of male cancer mortality.
Read More

Bioworld MedTech’s Neurology Extra for Dec. 6, 2019

Dec. 6, 2019
By Andrea Applegate
No Comments
Keeping you up to date on recent developments in neurology.
Read More

Bioworld MedTech’s Diagnostics Extra for Dec. 5, 2019

Dec. 5, 2019
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

Bioworld MedTech’s Orthopedics Extra for Dec. 4, 2019

Dec. 4, 2019
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More

Bioworld MedTech’s Oncology Extra for Dec. 3, 2019

Dec. 3, 2019
By Mark McCarty
No Comments
Keeping you up to date on recent developments in oncology.
Read More
‘Absolutely fascinating’

Stem cells, dead cells work equally well for heart repair

Dec. 2, 2019
By Anette Breindl
No Comments
A study published in the Nov. 27, 2019, advance online issue of Nature manages a rare feat. It is both a vindication of and egg in the face for cardiac stem cell research.
Read More
Blue puzzle pieces, red ribbon
World AIDS Day

Immediate ART initiation for neonates with HIV-1 provides significant results

Dec. 2, 2019
By Nuala Moran
No Comments
LONDON – Initiating antiretroviral treatment (ART) as soon as infants who are positive for HIV-1 infection are born has significant protective effects, with fewer viral reservoir cells and improved immune system development, according to new research.
Read More

Bioworld MedTech’s Cardiology Extra

Dec. 2, 2019
By Liz Hollis and Anette Breindl
No Comments
Keeping you up to date on recent developments in cardiology.
Read More
Petri dish and capsules
There’s an app for THAT?!

Web-based tool facilitates new antibiotic development

Nov. 27, 2019
By John Fox
No Comments
A new web-based tool allowing rapid in silico prediction of the ability of candidate antibiotics to accumulate in Gram-negative bacteria should enable subsequent prioritization of new compounds for synthesis and further evaluation, U.S. researchers reported Nov. 18, 2019, in Nature Microbiology.
Read More
Previous 1 2 … 115 116 117 118 119 120 121 122 123 … 131 132 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 18, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 18.
  • China U.S. deal

    Merck acquires global rights to cancer drug from Kelun in $1.4B deal

    BioWorld
    In a deal potentially worth more than $1.4 billion, Sichuan Kelun Pharmaceutical Co. Ltd. has out-licensed a large molecule drug in cancer to Merck & Co. Inc. for...
  • Hearing ear icon

    Cochlear to acquire rival Oticon Medical for $121M

    BioWorld MedTech
    Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing